NDR

(14beta,17alpha)-17-ethynyl-17-hydroxyestr-4-en-3-one

Find entries where: NDR

is present as a standalone ligand in 2 entries

Find related ligands:

Chemical Component Summary
Name	(14beta,17alpha)-17-ethynyl-17-hydroxyestr-4-en-3-one
Identifiers	(8R,9S,10R,13S,14S,17R)-17-ethynyl-17-hydroxy-13-methyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one
Formula	C₂₀ H₂₆ O₂
Molecular Weight	298.419
Type	NON-POLYMER
Isomeric SMILES	C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@]2(C#C)O)CCC4=CC(=O)CC[C@H]34
InChI	InChI=1S/C20H26O2/c1-3-20(22)11-9-18-17-6-4-13-12-14(21)5-7-15(13)16(17)8-10-19(18,20)2/h1,12,15-18,22H,4-11H2,2H3/t15-,16+,17+,18-,19-,20-/m0/s1
InChIKey	VIKNJXKGJWUCNN-XGXHKTLJSA-N

Chemical Details
Formal Charge	0
Atom Count	48
Chiral Atom Count	6
Bond Count	51
Aromatic Bond Count	0

Drug Info: DrugBank

DrugBank ID	DB00717
Name	Norethisterone
Groups	approved
Description	Norethisterone, also known as norethindrone, is a synthetic progestational hormone belonging to the 19-nortestosterone-derived class of progestins.[A10367] It is further classified as a second-generation progestin, along with [levonorgestrel] and its derivatives, and is the active form of several other progestins including [norethynodrel] and [lynestrenol].[A10367] Norethisterone mimics the actions of endogenous [progesterone], albeit with a greater potency,[A188075] and is used on its own or in combination with estrogen derivatives in a variety of applications including contraception and hormone replacement therapy.[L9527,L10301,L10304,L10307] First derived in 1951 in Mexico City, norethisterone was originally intended for use as a remedy for irregular menstruation and endometriosis, and was not marketed for use as an oral contraceptive until 1962.[L10439]
Synonyms	4-estren-17α-ethynyl-17β-ol-3-one 17-hydroxy-19-nor-17α-pregn-4-en-20-yn-3-one Noréthistérone 17α-ethinyl-19-nortestosterone 17-α-ethynyl-17-hydroxy-4-estren-3-one 19-nor-ethindrone 17α-ethynyl-17-hydroxy-4-estren-3-one 19-nor-17α-ethynyltestosterone 19-Nor-17alpha-ethynyl-17beta-hydroxy-4-androsten-3-one 19-norethisterone Norethisterone acetate Norethisteron 17α-ethynyl-19-norandrost-4-en-17β-ol-3-one 17-α-ethynyl-19-nortestosterone 17-α-ethynyl-19-norandrost-4-en-17-β-ol-3-one Norethindrone 19-nor-17-α-ethynyltestosterone 19-nor-17α-ethynyl-17β-hydroxy-4-androsten-3-one Norethisterone Noretisterona 17α-ethynyl-4-estren-17-ol-3-one (17alpha)-17-ethynyl-17-hydroxyestra-4,8(14),9-trien-3-one 17-α-ethynyl-4-estren-17-ol-3-one 19-nor-17-α-ethynylandrosten-17-β-ol-3-one 17-hydroxy-19-nor-17-α-pregn-4-en-20-yn-3-one 17α-ethynyl-17β-hydroxy-19-norandrost-4-en-3-one 19-nor-17-α-ethynyl-17-β-hydroxy-4-androsten-3-one 17α-ethynyl-19-nor-4-androsten-17β-ol-3-one 19-nor-17α-ethynylandrosten-17β-ol-3-one 17α-ethinylestra-4-en-17β-ol-3-one 17-β-hydroxy-19-norpregn-4-en-20-yn-3-one 17β-hydroxy-19-norpregn-4-en-20-yn-3-one Norethisteronum 17α-ethynyl-19-nortestosterone
Brand Names	Larin 24 Fe Estradiol / Norethindrone Acetate Brevicon 0.5/35 Tablets (21-day Pack) Finzala Cyclafem 1/35 Microgestin Fe 1/20 Aurovela Fe 1/20 Ortho 7/7/7 Tablets (28 Day) Synphasic-28 Tablets Microgestin Fe Ovcon 50 LOESTRIN 1/20 21 Day Ortho 10/11 Tablets (28 Day) Necon 1/35 (28 Day Regimen) Cyclafem 7/7/7 Microgestin 24 Fe Microgestin Fe 1.5/30 Nor QD Micronor Hailey 1.5/30 Norlyda Junel Fe 28 Day Estalis 140/50 Mcg Maeve Layolis Fe Modicon Tulana Loestrin 24 Fe Brevicon 1/35 28 Tab Merzee Vyfemla Errin Hailey 24 Fe Ortho 1/35 Tablets (21 Day) Ortho Novum 135 Etyqa Gemmily Junel 21 Day Heather Gildess 24 Fe ESTROSTEP Fe Lyza GENERESS Fe Gildess 1/20 Norethindrone and Ethinyl Estradiol, and Ferrous Fumarate Estradiol and Norethindrone Acetate Norethindrone Acetate and Ethinyl Estradiol and Ferrous Fumarate Brevicon 0.5/35 28 Tab Wymzya Fe Movisse Activelle Ld Zenchent FE Norinyl 1/50 28 Tab Norlutate Fyavolv Brevicon 0.5/35 21 Tab Lyleq Norlyroc Lopreeza Junel FE Synphasic 28 Tablets FEMCON Fe Incassia Jolivette Norethindrone Generess Aurovela 1/20 Larin Fe 1.5/30 Blisovi Fe 1.5/30 Alyacen 1/35 Larin Fe 1/20 Norethindrone Acetate Ortho 1/35 Tablets (28 Day) Ortho-novum 1/50 Tablets (28 Day) Ortho 0.5/35 Tablets (21 Day) Microgestin 1.5/30 Pirmella 1/35 Oshih Loestrin 21 Day Lo Minastrin Fe Aygestin Loestrin Fe 28 Day Brevicon 1/35 Tablets (28-day Pack) Gildess Fe 1.5/30 Necon 10/11 Norinyl 1/50 21 Tab Dasetta 7/7/7 Ortho-novum 1/50 Tablets (21 Day) Norethindrone and ethinyl estradiol and ferrous fumarate Camila Norinyl 1/50 -(21-day Regimen) Blisovi 24 Fe Necon Ortho-novum Kaitlib Fe LOESTRIN Fe 1.5/30 Philith Tarina 24 Fe Estalis 250/50 Mcg Necon (28 Day Regimen) Nylia 1/35 Junel 1.5/30 Nora-BE Norethindrone and ethinyl estradiol MICROGESTIN Fe 1.5/30 Loestrin 21 1/20 Estracomb WYMZYA Fe Ortho Novum 1/35 Select 1/35 (28-day) LOESTRIN Fe 1/20 Mimvey Lo Nortrel 28 Day Ryeqo Synphasic 21 Tablets Zenchent Nylia 7/7/7 LOESTRIN 1.5/30 21 Day HAILEY Fe 1/20 Tri-Norinyl Wera CombiPatch (estradiol/norethindrone acetate transdermal system) TARINA Fe 1/20 Jinteli Taysofy Lolo Ortho Micronor Briellyn Aurovela 1.5/30 Norinyl Rhuzdah Microgestin 1/20 Blisovi Fe 1/20 Microgestin Emzahh Brevicon Mibelas 24 Fe Micronor Tablets 28-day Aranelle LOESTRIN Fe 1/20 28 Day Lomedia 24 Fe Brevicon 1/35 21 Tab Necon 777 777 Aurovela 24 Fe Nexesta Fe Zenchent 0.4/35 Necon 1/35 Ortho 0.5/35 Tablets (28 Day) Larin 1/20 Melodetta 24 Fe Mimvey Nortrel (21 Day Regimen) Ovcon 35 Zeosa Norinyl 1/50 -(28-day Regimen) Activella Brevicon 0.5/35 Tablets (28-day Pack) Charlotte 24Fe Loestrin 1.5/30 Necon 0.5/35 Femhrt Nortrel 7/7/7 (28 Day Regimen) Pirmella 7/7/7 Jencycla Norethindrone acetate and ethinyl estradiol, and ferrous fumarate Alyacen 7/7/7 AUROVELA Fe Norethindrone Acetate and Ethinyl Estradiol, and Ferrous Fumarate Gildagia Myfembree Minestrin 1/20 Junel Fe 1.5/30 Activelle Gildess Fe 1/20 Jevantique Junel Fe 1/20 Junel Fe 24 Minastrin 24 Fe Taytulla Deblitane Affodel Ortho 7/7/7 Tablets (21 Day) Tilia Fe Oriahnn Norethindrone Acetate and Ethinyl Estradiol Leena Balziva Tarina Fe 1/20 EQ Ortho-novum 10/11 Nortrel 21 Day Larin 1.5/30 Loestrin 21 1.5/30 Norethindrone acetate Brevicon 1/35 Tablets (21-day Pack) Ortho-Novum 777 MICROGESTIN Fe 1/20 Select 1/35 (21-day) Cyonanz LOESTRIN Fe 1.5/30 28 Day Lupaneta Pack Estalis Sequi Tri-Legest Fe 28 Day Dasetta 1/35 Gildess 1.5/30 Nora BE CombiPatch Sharobel Necon 777 Lo Loestrin Fe Jevantique Lo Norethindrone and Ethinyl Estradiol and Ferrous Fumarate Amabelz Ortho 10/11 Tablets (21 Day) Hailey Fe 1.5/30
Indication	Norethisterone is indicated as an oral contraceptive when given as monotherapy[L9527] or in combination with an estrogen component, such as [ethinylestradiol] or [estradiol].[L10313,L10307] In combination with an estrogen component, oral norethisterone is also indicated as a hormone replacement therapy in the treatment of postmenopausal osteoporosis and moderate-to-severe vasomotor symptoms arising from menopause.[L10304] When applied via transdermal patch, the combination of norethisterone and estradiol is indicated for the treatment of hypoestrogenism, vulvovaginal atrophy, and moderate-severe vasomotor symptoms.[L10301] Norethisterone, taken in combination with intramuscular [leuprolide], is also indicated for the symptomatic treatment of endometriosis-related pain.[L10310]
Categories	Adrenal Cortex Hormones Anti-Gonadotropin-Releasing Hormones Combination Contraceptives (with Estrogen and derivatives) Contraceptive Agents, Female Contraceptive Agents, Hormonal Contraceptives, Oral Contraceptives, Oral, Hormonal Contraceptives, Oral, Synthetic Cytochrome P-450 CYP1A2 Substrates Cytochrome P-450 CYP2A6 Substrates Cytochrome P-450 CYP2C19 Inducers Cytochrome P-450 CYP2C19 Inducers (strength unknown) Cytochrome P-450 CYP2C19 Substrates Cytochrome P-450 CYP3A Substrates Cytochrome P-450 CYP3A4 Substrates Cytochrome P-450 CYP3A4 Substrates (strength unknown) Cytochrome P-450 CYP3A5 Substrates Cytochrome P-450 CYP3A7 Substrates Cytochrome P-450 Enzyme Inducers Cytochrome P-450 Substrates Estren Derivatives Fused-Ring Compounds Genito Urinary System and Sex Hormones Hormonal Contraceptives for Systemic Use Hyperglycemia-Associated Agents Hypothalamic Hormones Norpregnenes Norsteroids P-glycoprotein inhibitors Pituitary and Hypothalamic Hormones and Analogues Progestin Contraceptives Progestins Progestogens and Estrogens, Sequential Preparations Reproductive Control Agents Sex Hormones and Modulators of the Genital System Steroids Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins
ATC-Code	H01CC53 H01CC54 G03AA05 G03DC02 G03AB04 G03AC01 G03FA01 G03FB05
CAS number	68-22-4

Drug Targets

Name	Target Sequence	Pharmacological Action	Actions
Progesterone receptor	MTELKAKGPRAPHVAGGPPSPEVGSPLLCRPAAGPFPGSQTSDTLPEVSA...	unknown	agonist
Androgen receptor	MEVQLGLGRVYPRPPSKTYRGAFQNLFQSVREVIQNPGPRHPEAASAAPP...	unknown	agonist
Glucocorticoid receptor	MDSKESLTPGREENPSSVLAQERGDVMDFYKTLRGGATVKVSASSPSLAV...	unknown	agonist
Cytochrome P450 3A4	MALIPDLAMETWLLLAVSLVLLYLYGTHSHGLFKKLGIPGPTPLPFLGNI...	unknown	substrate
Aldo-keto reductase family 1 member C4	MDPKYQRVELNDGHFMPVLGFGTYAPPEVPRNRAVEVTKLAIEAGFRHID...	unknown	substrate
3 beta-hydroxysteroid dehydrogenase/Delta 5-->4-isomerase type 2	MGWSCLVTGAGGLLGQRIVRLLVEEKELKEIRALDKAFRPELREEFSKLQ...	unknown	substrate
3-oxo-5-alpha-steroid 4-dehydrogenase	MATATGVAEERLLAALAYLQCAVGCAVFARNRQTNSVYGRHALPSHRLRV...	unknown	substrate
3-oxo-5-beta-steroid 4-dehydrogenase	MDLSAASHRIPLSDGNSIPIIGLGTYSEPKSTPKGACATSVKVAIDTGYR...	unknown	substrate
Cytochrome P450 2C19	MDPFVVLVLCLSCLLLLSIWRQSSGRGKLPPGPTPLPVIGNILQIDIKDV...	unknown	substrate,inducer
Cytochrome P450 1A2	MALSQSVPFSATELLLASAIFCLVFWVLKGLRPRVPKGLKSPPEPWGWPL...	unknown	substrate
Cytochrome P450 2A6	MLASGMLLVALLVCLTVMVLMSVWQQRKSKGKLPPGPTPLPFIGNYLQLN...	unknown	substrate
Serum albumin	MKWVTFISLLFLFSSAYSRGVFRRDAHKSEVAHRFKDLGEENFKALVLIA...	unknown	substrate
Sex hormone-binding globulin	MESRGPLATSRLLLLLLLLLLRHTRQGWALRPVLPTQSAHDPPAVHLSNG...	unknown	substrate
P-glycoprotein 1	MDLEGDRNGGAKKKNFFKLNNKSEKDKKEKKPTVSVFSMFRYSNWLDKLY...	unknown	inhibitor
View More

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682